Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) reported a net profit attributable to shareholders of 105.6 million yuan for the quarter ended Sept. 30, a 13.13% decrease from the prior-year period, according to a Friday filing with the Hong Kong bourse.

Earnings per share were 0.45 yuan, an 11.76% drop from a year ago.

The revenue for the quarter was 670.4 million yuan, 0.22% more than the previous year's quarter.

The company's shares were down by almost 11% in recent trading.

Price (HKD): $30.25, Change: $-3.7, Percent Change: -10.77%